Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1990 Jun;43(6):448–452. doi: 10.1136/jcp.43.6.448

Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2.

E Heyderman 1, S E Larkin 1, P J O'Donnell 1, A M Haines 1, P J Warren 1, A Northeast 1, A G Grant 1
PMCID: PMC502494  PMID: 1696288

Abstract

Paraffin wax embedded, formalin fixed sections of 22 adenocarcinomas of the exocrine pancreas were stained with four mouse monoclonal antibodies: DD9-E7, an antibody raised against a human pancreatic tumour xenograft; carcino-embryonic antigen (CEA); epithelial membrane antigen (EMA); and cytokeratin (CAM 5.2). An indirect immunoperoxidase technique without enzyme pre-digestion and an affinity-purified sheep anti-mouse peroxidase conjugate were used. All of the tumours were positive for DD9-E7, EMA, and CAM 5.2. Twenty out of 22 were focally positive for CEA and the staining was often weak. As all of these adenocarcinomas were DD9-E7 positive, absence of staining for DD9-E7 in a tumour makes the diagnosis of adenocarcinoma of the exocrine pancreas very unlikely, and this is of value in distinction from endocrine carcinomas with a marked acinar pattern. The weak CEA staining distinguished pancreatic carcinomas from colorectal tumours. Because the distribution of staining for EMA and CAM 5.2 was no different from that previously seen in adenocarcinomas from other sites, these markers are likely to be of limited value in the differential diagnosis of abdominal adenocarcinomas of uncertain origin.

Full text

PDF
448

Images in this article

449Image
on p.449
449Image
on p.449
450Image
on p.450
450Image
on p.450
451Image
on p.451
451Image
on p.451

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers G. H., Fleuren G., Escribano M. J., Nap M. Immunohistochemistry of CEA in the human pancreas during development, in the adult, chronic pancreatitis, and pancreatic adenocarcinoma. Am J Clin Pathol. 1988 Jul;90(1):17–22. doi: 10.1093/ajcp/90.1.17. [DOI] [PubMed] [Google Scholar]
  2. Allum W. H., Stokes H. J., Macdonald F., Fielding J. W. Demonstration of carcinoembryonic antigen (CEA) expression in normal, chronically inflamed, and malignant pancreatic tissue by immunohistochemistry. J Clin Pathol. 1986 Jun;39(6):610–614. doi: 10.1136/jcp.39.6.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Atkinson B. F., Ernst C. S., Herlyn M., Steplewski Z., Sears H. F., Koprowski H. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res. 1982 Nov;42(11):4820–4823. [PubMed] [Google Scholar]
  4. Borowitz M. J., Tuck F. L., Sindelar W. F., Fernsten P. D., Metzgar R. S. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. J Natl Cancer Inst. 1984 May;72(5):999–1005. [PubMed] [Google Scholar]
  5. Burtin P., Chavanel G., Hirsch-Marie H. Characterization of a second normal antigen that cross-reacts with CEA. J Immunol. 1973 Dec;111(6):1926–1928. [PubMed] [Google Scholar]
  6. Bätge B., Bosslet K., Sedlacek H. H., Kern H. F., Klöppel G. Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias. Virchows Arch A Pathol Anat Histopathol. 1986;408(4):361–374. doi: 10.1007/BF00707694. [DOI] [PubMed] [Google Scholar]
  7. Connolly M. M., Dawson P. J., Michelassi F., Moossa A. R., Lowenstein F. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg. 1987 Sep;206(3):366–373. doi: 10.1097/00000658-198709000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cordell J., Richardson T. C., Pulford K. A., Ghosh A. K., Gatter K. C., Heyderman E., Mason D. Y. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer. 1985 Sep;52(3):347–354. doi: 10.1038/bjc.1985.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Denk H., Tappeiner G., Eckerstorfer R., Holzner J. H. Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation. Int J Cancer. 1972 Sep 15;10(2):262–272. doi: 10.1002/ijc.2910100206. [DOI] [PubMed] [Google Scholar]
  10. GOLD P., FREEDMAN S. O. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965 Mar 1;121:439–462. doi: 10.1084/jem.121.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goldenberg D. M., Sharkey R. M., Primus F. J. Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens. Cancer. 1978 Sep;42(3 Suppl):1546–1553. doi: 10.1002/1097-0142(197809)42:3+<1546::aid-cncr2820420829>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  12. Grant A. G., Duke D., Hermon-Taylor J. Establishment and characterization of primary human pancreatic carcinoma in continuous cell culture and in nude mice. Br J Cancer. 1979 Feb;39(2):143–151. doi: 10.1038/bjc.1979.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grant A. G., Harris P. M., Heyderman E., Larkin S. E., Pym B., Hermon-Taylor J. The generation of monoclonal antibodies against human pancreatic exocrine cancer: a study of six different immunisation regimes. Br J Cancer. 1985 Oct;52(4):543–550. doi: 10.1038/bjc.1985.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Haines A. M., Larkin S. E., Richardson A. P., Stirling R. W., Heyderman E. A novel hybridoma antibody (PASE/4LJ) to human prostatic acid phosphatase suitable for immunohistochemistry. Br J Cancer. 1989 Dec;60(6):887–892. doi: 10.1038/bjc.1989.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Heyderman E., Brown B. M., Richardson T. C. Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase. J Clin Pathol. 1984 Dec;37(12):1363–1369. doi: 10.1136/jcp.37.12.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Heyderman E., Neville A. M. A shorter immunoperoxidase technique for the demonstration of carcinoembryonic antigen and other cell products. J Clin Pathol. 1977 Feb;30(2):138–140. doi: 10.1136/jcp.30.2.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Heyderman E., Steele K., Ormerod M. G. A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue. J Clin Pathol. 1979 Jan;32(1):35–39. doi: 10.1136/jcp.32.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Heyderman E., Strudley I., Powell G., Richardson T. C., Cordell J. L., Mason D. Y. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2. Br J Cancer. 1985 Sep;52(3):355–361. doi: 10.1038/bjc.1985.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Heyderman E., Warren P. J., Haines A. M. Immunocytochemistry today--problems and practice. Histopathology. 1989 Dec;15(6):653–658. doi: 10.1111/j.1365-2559.1989.tb01635.x. [DOI] [PubMed] [Google Scholar]
  20. Ho M. K., Kato K. P., Durda P. J., Murray J. H., Wolfe H., Rabin H., Carney W. P. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein. Cancer Res. 1987 Jan 1;47(1):241–250. [PubMed] [Google Scholar]
  21. Ichihara T., Nagura H., Nakao A., Sakamoto J., Watanabe T., Takagi H. Immunohistochemical localization of CA 19-9 and CEA in pancreatic carcinoma and associated diseases. Cancer. 1988 Jan 15;61(2):324–333. doi: 10.1002/1097-0142(19880115)61:2<324::aid-cncr2820610223>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  22. Ichihara T., Nakao A., Sakamoto J., Nonami T., Harada A., Watanabe T., Takagi H., Nagura H. Application of the immunoperoxidase method for rapid intraoperative pathological diagnosis of pancreatic cancer. J Surg Oncol. 1989 Jan;40(1):8–16. doi: 10.1002/jso.2930400105. [DOI] [PubMed] [Google Scholar]
  23. Kalser M. H., Barkin J. S., Redlhammer D., Heal A. Circulating carcinoembryonic antigen in pancreatic carcinoma. Cancer. 1978 Sep;42(3 Suppl):1468–1471. doi: 10.1002/1097-0142(197809)42:3+<1468::aid-cncr2820420816>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  24. Kuusela P., Haglund C., Roberts P. J., Jalanko H. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. Br J Cancer. 1987 Jun;55(6):673–676. doi: 10.1038/bjc.1987.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Laurence D. J., Stevens U., Bettelheim R., Darcy D., Leese C., Turberville C., Alexander P., Johns E. W., Neville A. M. Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Br Med J. 1972 Sep 9;3(5827):605–609. doi: 10.1136/bmj.3.5827.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lo Gerfo P., Li Volsi V., Colacchio D., Feind C. Thyroglobulin production by thyroid cancers. J Surg Res. 1978 Jan;24(1):1–6. doi: 10.1016/0022-4804(78)90014-8. [DOI] [PubMed] [Google Scholar]
  27. Mach J. P., Pusztaszeri G. Carcinoembryonic antigen (CEA): demonstration of a partial identity between CEA and a normal glycoprotein. Immunochemistry. 1972 Oct;9(10):1031–1034. doi: 10.1016/0019-2791(72)90113-9. [DOI] [PubMed] [Google Scholar]
  28. Makin C. A., Bobrow L. G., Bodmer W. F. Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol. 1984 Sep;37(9):975–983. doi: 10.1136/jcp.37.9.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Morohoshi T., Kanda M., Horie A., Chott A., Dreyer T., Klöppel G., Heitz P. U. Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor. Cancer. 1987 Feb 15;59(4):739–747. doi: 10.1002/1097-0142(19870215)59:4<739::aid-cncr2820590413>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  30. Nakane P. K., Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem. 1974 Dec;22(12):1084–1091. doi: 10.1177/22.12.1084. [DOI] [PubMed] [Google Scholar]
  31. Nap M., ten Hoor K. A., Fleuren G. J. Cross-reactivity with normal antigens in commercial anti-CEA sera, used for immunohistology. The need for tissue controls and absorptions. Am J Clin Pathol. 1983 Jan;79(1):25–31. doi: 10.1093/ajcp/79.1.25. [DOI] [PubMed] [Google Scholar]
  32. Neville A. M., Cooper E. H. Biochemical monitoring of cancer. A review. Ann Clin Biochem. 1976 Jan;13(1):283–305. doi: 10.1177/000456327601300101. [DOI] [PubMed] [Google Scholar]
  33. Ona F. V., Zamcheck N., Dhar P., Moore T., Kupchik H. Z. Carcinoembryonic antigen (CEA) in the diagnosis of pancreatic cancer. Cancer. 1973 Feb;31(2):324–327. doi: 10.1002/1097-0142(197302)31:2<324::aid-cncr2820310208>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  34. Tsutsumi Y., Nagura H., Watanabe K. Immunohistochemical observations of carcinoembryonic antigen (CEA) and CEA-related substances in normal and neoplastic pancreas. Pitfalls and caveats in CEA immunohistochemistry. Am J Clin Pathol. 1984 Nov;82(5):535–542. doi: 10.1093/ajcp/82.5.535. [DOI] [PubMed] [Google Scholar]
  35. Wilson N. W., Pambakian H., Richardson T. C., Stokoe M. R., Makin C. A., Heyderman E. Epithelial markers in thyroid carcinoma: an immunoperoxidase study. Histopathology. 1986 Aug;10(8):815–829. doi: 10.1111/j.1365-2559.1986.tb02580.x. [DOI] [PubMed] [Google Scholar]
  36. von Kleist S., Chavanel G., Burtin P. Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2492–2494. doi: 10.1073/pnas.69.9.2492. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES